Symmetrel

E804596

Symmetrel is a brand-name antiviral and antiparkinsonian medication whose active ingredient is amantadine.

Try in SPARQL Jump to: Statements Referenced by

Statements (48)

Predicate Object
instanceOf antiparkinsonian medication
antiviral medication
brand-name drug
belongsTo human prescription drug
contraindicatedIn known hypersensitivity to amantadine
severe renal impairment without dose adjustment
developedFrom amantadine hydrochloride
hasActiveIngredient amantadine
hasAdverseEffect confusion
dizziness
hallucinations
insomnia
livedo reticularis
nausea
peripheral edema
hasATCCode J05BB01
N04BB01
hasChemicalSubstance amantadine hydrochloride NERFINISHED
hasDosageForm capsule
oral solution
hasEffect reduces Parkinsonian bradykinesia
reduces Parkinsonian rigidity
reduces levodopa-induced dyskinesia
hasLegalStatus prescription-only medicine in many countries
hasMechanismOfAction blocks dopamine reuptake
blocks influenza A M2 ion channel
increases dopamine release in the central nervous system
hasOriginCountry United States NERFINISHED
hasPharmacologicClass adamantane antiviral
dopaminergic agent
hasPregnancyCategory C (US, historical)
hasRouteOfAdministration oral
laterApprovedFor treatment of Parkinson's disease
treatment of drug-induced extrapyramidal reactions
mayCause anticholinergic-like side effects
impulse control disorders
orthostatic hypotension
metabolizedBy kidney excretion
requiresCautionIn elderly patients
patients with congestive heart failure
patients with psychiatric disorders
patients with seizure disorders
tradeNameOf amantadine NERFINISHED
usedAs adjunct therapy in Parkinson's disease
usedFor treatment of Parkinson's disease
treatment of drug-induced extrapyramidal symptoms
treatment of influenza A infection
wasFirstApprovedFor prophylaxis and treatment of influenza A

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

amantadine hasBrandName Symmetrel